|

The Genotype and Phenotype of Lymphangioleiomyomatosis

RECRUITINGSponsored by National Taiwan University Hospital
Actively Recruiting
SponsorNational Taiwan University Hospital
Started2024-05-10
Est. completion2027-07-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06405997

Summary

This study aims to differentiate between sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex-associated Lymphangioleiomyomatosis.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* age ≥ 18 y/o
* Patient with Chest CT showed cystic lung disease, suspected Lymphangioleiomyomatosis

Exclusion Criteria:

* age \< 18 y/o

Conditions3

CancerSporadic LymphangioleiomyomatosisTSC-associated Lymphangioleiomyomatosis

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.